SEHK Growth Companies With Up To 38% Insider Ownership

In This Article:

In recent trading sessions, the Hong Kong market has shown positive momentum, with the Hang Seng Index climbing 2.64%, reflecting a buoyant mood spurred by strong holiday spending and recovery hopes. This backdrop provides an interesting context for examining growth companies in Hong Kong, particularly those with high insider ownership, which can be a marker of confidence in the company's future from those who know it best.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

iDreamSky Technology Holdings (SEHK:1119)

20.1%

104.1%

New Horizon Health (SEHK:6606)

16.6%

61%

Meitu (SEHK:1357)

38%

34.3%

Adicon Holdings (SEHK:9860)

22.3%

29.6%

DPC Dash (SEHK:1405)

38.2%

91.5%

Tian Tu Capital (SEHK:1973)

34%

70.5%

Zhejiang Leapmotor Technology (SEHK:9863)

14.2%

74%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

15.7%

100.1%

Ocumension Therapeutics (SEHK:1477)

17.7%

93.7%

Beijing Airdoc Technology (SEHK:2251)

26.4%

83.9%

Click here to see the full list of 52 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Zylox-Tonbridge Medical Technology

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zylox-Tonbridge Medical Technology Co., Ltd. is a medical device company specializing in neuro- and peripheral-vascular interventional devices, operating both in the People’s Republic of China and internationally, with a market capitalization of approximately HK$3.51 billion.

Operations: The company generates revenue primarily through the sale of neurovascular and peripheral-vascular interventional surgical devices, totaling CN¥527.75 million.

Insider Ownership: 18.3%

Zylox-Tonbridge Medical Technology Co., Ltd., a Hong Kong-based growth company with high insider ownership, is trading at 44.6% below its estimated fair value. The firm is expected to become profitable within three years, with earnings forecasted to grow by 79.31% annually. Additionally, revenue growth is anticipated at 23.5% per year, outpacing the Hong Kong market average of 8.1%. Recent strategic partnerships and new product approvals in international markets underline its expansion efforts and innovative edge in medical technology.

SEHK:2190 Earnings and Revenue Growth as at May 2024
SEHK:2190 Earnings and Revenue Growth as at May 2024

IGG

Simply Wall St Growth Rating: ★★★★☆☆

Overview: IGG Inc is an investment holding company that develops and operates mobile and online games across Asia, North America, Europe, and other international markets, with a market capitalization of approximately HK$3.82 billion.